Manuel Litchman MD - 24 Apr 2023 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Jul 2023, 16:06:00 UTC
Prior SEC filing
04 Jun 2024
Next SEC filing
04 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Matthew Wein, Attorney-in-Fact

Key filing fact

Manuel Litchman MD filed Form 4 for MUSTANG BIO, INC. (MBIO) on 07 Jul 2023.

Key facts

  • This page summarizes Manuel Litchman MD's Form 4 filing for MUSTANG BIO, INC. (MBIO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 07 Jul 2023, 16:06.

Change

  • Previous filing in this sequence was filed on 04 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MBIO transaction

COMMON STOCK, PAR VALUE $0.0001

Award

Transaction value
$0
Shares
+5,000
Change %
+4.7%
Price
$0.000000
Shares after
111,079
Date
24 Apr 2023
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027.

Footnote F2

Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.

Footnote F3

Includes restricted share units, which vest over various time periods.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .